Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1979 1
1980 1
1982 1
1992 1
1993 1
1995 2
1996 2
1997 2
1998 1
1999 3
2000 2
2001 1
2002 4
2003 6
2004 7
2005 1
2006 1
2007 1
2008 2
2009 4
2010 7
2011 2
2012 4
2013 2
2014 6
2015 2
2016 2
2017 5
2018 4
2019 3
2020 7
2021 16
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
Kavanagh JE, Hearn AP, Dhariwal J, d'Ancona G, Douiri A, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Kent BD, Jackson DJ. Kavanagh JE, et al. Among authors: hearn ap. Chest. 2021 Feb;159(2):496-506. doi: 10.1016/j.chest.2020.08.2083. Epub 2020 Aug 31. Chest. 2021. PMID: 32882249
Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury.
Widjaja AA, Dong J, Adami E, Viswanathan S, Ng B, Pakkiri LS, Chothani SP, Singh BK, Lim WW, Zhou J, Shekeran SG, Tan J, Lim SY, Goh J, Wang M, Holgate R, Hearn A, Felkin LE, Yen PM, Dear JW, Drum CL, Schafer S, Cook SA. Widjaja AA, et al. Among authors: hearn a. Sci Transl Med. 2021 Jun 9;13(597):eaba8146. doi: 10.1126/scitranslmed.aba8146. Sci Transl Med. 2021. PMID: 34108253
Biologic treatment options for severe asthma.
Hearn AP, Kent BD, Jackson DJ. Hearn AP, et al. Curr Opin Immunol. 2020 Oct;66:151-160. doi: 10.1016/j.coi.2020.10.004. Epub 2020 Nov 16. Curr Opin Immunol. 2020. PMID: 33212388 Review.
Natural endogenous adjuvants.
Rock KL, Hearn A, Chen CJ, Shi Y. Rock KL, et al. Among authors: hearn a. Springer Semin Immunopathol. 2005 Jan;26(3):231-46. doi: 10.1007/s00281-004-0173-3. Epub 2004 Oct 14. Springer Semin Immunopathol. 2005. PMID: 15609001 Review.
Cervical SNAGs: a biomechanical analysis.
Hearn A, Rivett DA. Hearn A, et al. Man Ther. 2002 May;7(2):71-9. doi: 10.1054/math.2002.0440. Man Ther. 2002. PMID: 12151243 Review.
Osteoporosis in multiple sclerosis.
Hearn AP, Silber E. Hearn AP, et al. Mult Scler. 2010 Sep;16(9):1031-43. doi: 10.1177/1352458510368985. Epub 2010 Jun 15. Mult Scler. 2010. PMID: 20551086 Review.
Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.
Munoz Pinto MF, Campbell SJ, Simoglou Karali C, Johanssen VA, Bristow C, Cheng VWT, Zarghami N, Larkin JR, Pannell M, Hearn A, Chui C, Brinquis Nunez B, Bokma E, Holgate R, Anthony DC, Sibson NR. Munoz Pinto MF, et al. Among authors: hearn a. Neuro Oncol. 2022 Jan 5;24(1):52-63. doi: 10.1093/neuonc/noab177. Neuro Oncol. 2022. PMID: 34297105 Free PMC article.
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
Nanzer AM, Taylor V, Hearn AP, Kavanagh JE, Patrick T, Green L, Thomson L, Lam J, Fernandes M, Roxas C, d'Ancona G, Kent BD, Dhariwal J, Jackson DJ. Nanzer AM, et al. Among authors: hearn ap. Eur Respir J. 2023 Aug 3;62(2):2300245. doi: 10.1183/13993003.00245-2023. Print 2023 Aug. Eur Respir J. 2023. PMID: 37474156 No abstract available.
112 results